Stay updated on Pembrolizumab in MSI Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The record history gains a new revision entry v3.6.3, and the prior revision v3.6.2 is removed from the visible changes.
    Difference
    0.1%
    Check dated 2026-07-05T14:30:20.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The history now includes a new revision entry v3.6.2, indicating a subsequent update to the record. The previous revision v3.6.0 is no longer listed in the history.
    Difference
    0.1%
    Check dated 2026-06-28T08:39:13.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The study record now states 'No longer looking for participants', indicating recruitment is closed for this trial. The revision line shows 'Revision: v3.6.0' replacing the previous 'Revision: v3.5.5', signaling an updated version of the study record.
    Difference
    0.3%
    Check dated 2026-06-14T00:23:41.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new site revision entry (v3.5.5) is added to the record history, replacing the previous revision (v3.5.4) and signaling an updated deployment of the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-06-06T19:40:08.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a newer software version has been applied to the page.
    Difference
    0.1%
    Check dated 2026-05-16T09:12:37.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A minor update to the ClinicalTrials.gov interface version is reflected in the page footer, moving from revision v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T22:19:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.